Back to Trades
Schilke Tobin
Chief Financial OfficerCIK 0001678984
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Schilke Tobin, Chief Financial Officer, has disclosed $266.3K in transactions — all concentrated in Crinetics Pharmaceuticals, Inc. (CRNX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $266.3K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Mar 4 | CRNX Crinetics Pharmaceuticals, Inc. | Schilke Tobin | Chief Financial Officer | Sell | $266.3K |
1 filing